Congenital bone marrow failure syndromes

British Journal of Haematology

Volumn 111, Issue 1, 2000, Pages 30-42

  Sieff, Colin A ^a,c   Nisbet Brown, Eric ^a   Nathan, David G ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Bone marrow failure; Congenital; Gene; Haematopoiesis

Indexed keywords

BLACKFAN DIAMOND ANEMIA; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; DISEASE COURSE; DYSKERATOSIS CONGENITA; ERYTHROCYTE APLASIA; FANCONI ANEMIA; HUMAN; NEUTROPENIA; PANCYTOPENIA; PEARSON SYNDROME; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

ANEMIA, SIDEROBLASTIC; BONE MARROW DISEASES; DYSKERATOSIS CONGENITA; FANCONI ANEMIA; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEUTROPENIA; PANCREATIC DISEASES; SYNDROME;

EID: 0033768437     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02263.x     Document Type: Review

References (135)

1. Fanconi's anemia and malignancies
2. The bone marrow failure syndromes
3. Clonal chromosomal abnormalities in Fanconi's anaemia: What do they really mean?
4. Characterization of a novel Minute-locus in Drosophila melanogaster: A putative ribosomal protein gene
5. Cyclic neutropenia: Proliferative and survival characteristics of bone marrow hematopoietic cells
6. Fanconi anemia diagnosis and the diepoxybutane (DEB) test
7. International Fanconi Anemia Registry (IFAR). Survival and prognostic factors
8. Diamond-Blackfan anaemia in the UK analysis of 80 cases from a 20-year birth cohort
9. Sustained response after recombinant interleukin-3 in Diamond Blackfan anemia
10. Contribution a l'etude clinique et pathophysiologique de la maladie de Fanconi
11. High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone
12. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in Patients with congenital agranulocytosis
13. Successful hematopoietic reconstitution by transplantation of umbilical cord blood cells in a transfusion-dependent child with Diamond-Blackfan anemia
14. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia
15. Congenitale hypoplastische anemie in Nederland (1963-89)
16. Age-related alterations in erythroid and granulopoietic progenitors in Diamond-Blackfan anaemia
17. Fanconi's disease and cancer of the liver
18. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia
19. Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation
20. Unrelated donor bone marrow transplantation for Fanconi anemia
21. Congenital pancytopenia associated with multiple congenital anomalies (Fanconi type)
22. The Fanconi anaemia group C gene FANCG is identical with XRCC9
23. Allogeneic bone marrow transplantation for Fanconi anemia
24. Hypoplastic anemia
25. Congenital hypoplastic anemia
26. Dyskeratosis congenita: An inherited bone marrow failure syndrome
27. Distinct cytoplasmic regions of the human G-CSF receptor involved in induction of proliferation and maturation
28. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia
29. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia
30. Dyskeratosis congenita: Clinical and genetic heterogeneity. Report of a new case and review of the literature
31. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia
32. Bone-marrow microenvironment defect in congenital hypoplastic anemia
33. Ribosomal heterogeneity from chromatin diminution in Ascaris lumbricoides
34. Homologous ribosomal protein genes on the human X and Y chromosomes: Escape from X inactivation and possible implications for Turner syndrome
35. Marrow transplantation for Fanconi anemia with or without leukemic transformation: An update of the Seattle experience
36. Diamond Blackfan syndrome. Evidence against cell-mediated erythropoietic suppression
37. Erythroid colony growth in congenital hypoplastic anemia
38. Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer
39. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex
40. Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.2-23.1 and for non-19q non-8p disease
41. Congenital agranulocytosis, prolonged survival and terminal acute leukemia
42. Diagnosis and management of red cell aplasia in children
43. Elevated red cell adenosine deaminase activity. A marker of disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic diseases
44. Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia
45. Radiosensitivity in Fanconi anaemia: Application to the conditioning regimen for bone marrow transplantation
46. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from and HLA-identical sibling
47. Bone marrow transplantation for Fanconi anemia
48. Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome)
49. Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia
50. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with Fanconi anemia
51. Diamond-Blackfan anaemia in a girl with a de novo balanced reciprocal X; 19 translocation
52. Diamond-Blackfan anemia. Genetic homogeneity for a gene on chromosome 19q13 restricted to 1.8 Mb
53. Identification of microdeletions spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity
54. Diamond-Blackfan anaemia
55. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions
56. Diamond-Blackfan syndrome: Lymphocyte mediated suppression of erythropoiesis
57. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis
58. Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia
59. Diamond-Blackfan anemia. Natural history and sequelae of treatment
60. Evidence for at least eight Fanconi anemia genes
61. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma
62. Anaemia of infancy and early childhood
63. Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment
64. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia
65. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation
66. A Drosophila minute gene encodes a ribosomal protein
67. Diamond Blackfan anemia
68. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase
69. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex
70. Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia
71. The box H+ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase
72. Sequence variation in the Fanconi anemia FAA gene
73. Genetic variations of Drosophila melanogaster
74. Aplastic and hypoplastic anemia
75. Defective erythroid progenitor differentiation system in congenital hypoplastic (Diamond-Blackfan) anemia
76. Gene transfer for the eventual treatment of Fanconi's anemia
77. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients
78. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC)
79. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA
80. Dyskeratosis and ribosomal rebellion
81. Pancytopenia with congenital defects (Fanconi's anemia)
82. Diamond-Blackfan anaemia. Three patterns of in vitro response to haemopoietic growth factors
83. NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria
84. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia
85. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
86. Functional activity of the Fanconi anemia protein FAA requires FAC binding and nuclear localization
87. Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia
88. Treatment trial with recombinant human erythropoietin in children with congenital hypoplastic anemia
89. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB
90. Iron-chelating therapy and the treatment of thalassemia
91. The Fanconi anemia group A gene product is a component of the IkB kinase signalsome complex involved in Nf-kB activation
92. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction
93. Successful bone marrow transplant for Fanconi anaemia in transformation
94. Blood mononuclear cells from patients with severe congenital neutropenia are capable of producing granulocyte colony-stimulating factor
95. Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element
96. Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer
97. Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia, a pilot study
98. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells
99. The protein tyrosine kinase JAK2 is activated in neutrophils from patients with severe congenital neutropenia
100. Congenital agranulocytosis terminating in acute myelomonocytic leukemia
101. Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy
102. The hemopoietic action of androstanes
103. Molecular and genetic analyses of two patients with Pearson's marrow-pancreas syndrome
104. Mutations of the Fanconi anemia group A (FAA) gene in Italian patients
105. Evaluation of growth and of endocrine systems in testosterone-corticosteroid-treated patients with aplastic anemia
106. Testosterone-induced remission in aplastic anemia
107. Pure red cell aplasia
108. Mutations in the Drosophila gene encoding ribosomal protein S6 cause tissue overgrowth
109. Cloning of cDNAs for Fanconi's anaemia by functional complementation
110. Bilateral basal ganglial necrosis after allogeneic bone marrow transplantation in a child with Kostmann syndrome
111. An IRE-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
112. Positional cloning of the Fanconi anemia group A gene
113. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia
114. Mutation analysis of the Fanconi anemia gene FACC
115. Cord blood stem cell transplantation for Diamond-Blackfan anemia
116. Bone marrow failure in children
117. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors. Analysis of engraftment and acute graft-versus-host disease
118. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism
119. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA
120. Overexpression of the Fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis
121. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia
122. The ribosomal genes of yeast and their regulation
123. Drosophila homolog of the human S6 ribosomal protein is required for tumor suppression in the hematopoietic system
124. Severe chronic neutropenia: Pathophysiology and therapy
125. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia
126. A common mutation in the FACC gene causes Fanconi anemia in Ashkenazi Jews
127. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene
128. Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene
129. High adenosine deaminase level among healthy probands of Diamond-Blackfan anemia (DBA) cosegregates with the DBA gene region on chromosome 19q13
130. Mutations in Ribosomal Protein S19 gene and Diamond-Blackfan anemia. Wide variations in phenotypic expression
131. Mammalian ribosomes: The structure and the evolution of the proteins
132. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation
133. Correction of fatal genetic diseases using bone marrow transplantation. 2
134. Unrelated donor bone marrow transplantation in Fanconi anaemia: The Leiden experience